Showing 1,641 - 1,660 results of 8,567 for search 'Pangda~', query time: 1.80s Refine Results
  1. 1641
  2. 1642
  3. 1643
  4. 1644
  5. 1645

    Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: A genomic epidemiology study by Gillian AM Tarr, Linda Chui, Kim Stanford, Emmanuel W Bumunang, Rahat Zaheer, Vincent Li, Stephen B Freedman, Chad R Laing, Tim A McAllister

    Published 2025-01-01
    “…To assess the impact of persistent cross-species transmission systems on the epidemiology of E. coli O157:H7 in Alberta, Canada, we sequenced and assembled E. coli O157:H7 isolates originating from collocated cattle and human populations, 2007–2015. …”
    Get full text
    Article
  6. 1646
  7. 1647
  8. 1648
  9. 1649
  10. 1650

    A Redescription of the Bulla, Antennae, and Mouth Parts of Female Clavella sp. (Copepoda: Siphonostomatoida: Lernaeopodidae) Infesting Wild Gadus morhua Using Scanning Electron Mic... by Harry M. Murray, Jacqueline M. Hanlon, Kimberly Marshall, Corey Morris

    Published 2020-01-01
    “…This study reports on the occurrence of a lernaeopodid infestation of wild-sourced Gadus morhua sampled from separate inshore (Gilbert Bay, NL) and offshore (Virgin Rocks, NL) populations from Newfoundland, Canada. The majority of the parasites were observed to be associated with the buccal cavity, gill filaments, gill arch, and occasionally near the outer edge of the operculum. …”
    Get full text
    Article
  11. 1651

    Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort by Robert J. Petrella, Julie Blouin, Brian Davies, Martin Barbeau

    Published 2012-01-01
    “…This data can help to inform evaluation of current DME treatment patterns and of proposed new treatment on drug plan budgets in Canada.…”
    Get full text
    Article
  12. 1652

    Effects of nurse-home visiting on intimate partner violence and maternal income, mental health and self-efficacy by 24 months postpartum: a randomised controlled trial (British Col... by Susan Jack, Charlotte Waddell, Michael Boyle, Harriet MacMillan, Yufei Zheng, Hui Xie, Colleen Varcoe, Amiram Gafni, Andrea Gonzalez, Debbie Sheehan, Lil Tonmyr, Ronald Barr, Lenora Marcellus, Nicole L A Catherine

    Published 2025-01-01
    “…Objective To evaluate the impact of Nurse-Family Partnership (NFP), a home-visiting programme, on exploratory maternal outcomes in British Columbia (BC), Canada.Design Pragmatic, parallel arm, randomised controlled trial conducted October 2013–November 2019. …”
    Get full text
    Article
  13. 1653

    The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C by Nicholas van Buuren, Lorraine Fradette, Jason Grebely, Alexandra King, Mel Krajden, Sonya A. MacParland, Alison Marshall, Sahar Saeed, Joyce Wilson, Marina B. Klein, Selena M. Sagan

    Published 2016-01-01
    “…Both the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) have identified HCV-related liver disease as a priority and supported the establishment of a National Hepatitis C Research Network. …”
    Get full text
    Article
  14. 1654
  15. 1655
  16. 1656
  17. 1657
  18. 1658

    Does Vibrio Vulnificus Present a Health Threat to Canadians? by Stanislava Stavric, Barbara Buchanan

    Published 1997-01-01
    “…OBJECTIVE: To review recent data on Vibrio vulnificus and its properties, characteristics of disease and epidemiology, sources of infection, population at risk, infectious dose, documented cases of infection and health risk from V vulnificus infection in Canada.…”
    Get full text
    Article
  19. 1659
  20. 1660

    Medical Management of Inflammatory Bowel Disease among Canadian Gastroenterologists by J Jones, R Panaccione, ML Russell, R Hilsden

    Published 2011-01-01
    “…BACKGROUND: Little is known about physician perceptions of and practices in using infliximab – a biological agent that was approved in Canada for the treatment of Crohn’s disease in 2001, and for ulcerative colitis in 2006.…”
    Get full text
    Article